How Bangkok clinics decide between umbilical cord MSCs and adipose-derived stem cells, what factors weigh in, and how patients can ask informed questions.
Two of the most commonly discussed cell sources in Bangkok are umbilical cord MSCs and adipose-derived stem cells. Both are legitimate options - they simply suit different cases.
Source decision is rarely arbitrary.
Each source has unique handling and oversight.
The choice influences the experience.
Patients should understand both paths.
Informed patients make better decisions.
Clinics should answer all of these clearly.
Umbilical cord MSCs come from screened donor tissue processed in certified labs, while adipose-derived MSCs come from the patient's own fat tissue and require a small harvesting procedure. Reputable Bangkok clinics document the sourcing, screening, and lab standards behind each option.
Patients travelling from abroad to Thailand should verify lab licensing, physician credentials, infection screening protocols, and follow-up support before committing. These checks matter more than the marketing language around umbilical cord or adipose stem cell therapy.
| Factor | Cord MSCs | Adipose Cells | ||
|---|---|---|---|---|
| Collection | No surgery | Mini-procedure | ||
| Type | Allogeneic | Often autologous | ||
| Screening | Donor batch | Personal | ||
| Use | Joint, IV | Joint, soft tissue |
Both umbilical cord MSCs and adipose-derived stem cells have legitimate roles - what matters is matching the source to the case and the patient.